Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Fluids and Fluid Resuscitation Mariusz Bral Marcel Abouassaly Alisha Mills NOSM Outline Overview of total body fluids and assessment of fluid status Colloids Crystalloids Resuscitation Why do we worry about fluids? Body water used in a variety of mechanisms to maintain homeostasis Metabolism Excretion of solutes Maintenance of intravascular volume How much do we need? Maintenance fluid replacement Approximately 1600cc/day in normal healthy adult Sensible losses • Stool: 200cc/day • Urine: 500cc/day (minimum) • Sweating: 100cc/day Insensible losses • Skin and respiratory tract: 800cc/day Review of Total Body Water Total body water = 60% of weight (50% in females) Intracellular water = 2/3 Extracellular water = 1/3 • • interstitial = 75% intravascular = 25% Assessing fluid status SSx Tachycardia Supine Hypotension Postural Hypotension Postural Pulse Increment JVP Pedal edema Dry mucous membranes Concentrated urine Passive leg raise Numerical values Urine output CXR for pulm edema CVP MAP Cardiac filling pressures Elevated BUN Persistent metabolic alkalosis Colloids Dictates movement of fluid between compartments What are Colloids? Large molecules that do not move out of vascular compartment Create osmostic pressure called Colloid Osmotic Pressure Favours retention of water in vascular compartment Colloid Osmotic Pressure Q=(Pc-COP) How good are Colloids? Colloid fluid is approximately 3 times more effective than crystalloid fluid for increasing plasma volume. Available colloids Voluven Pentaspan 5% Albumin 25% Albumin Blood Voluven 6% Hydroxyethyl starch 130/0.4 in 0.9%NS Osmolarity 308 mosm/L pH: 4.0-5.5 Plasma expansion of 1.3 x volume infused What is it made of? Sodium 154 mmol Chloride 154 mmol Polystarch 6.00g Voluven Duration of action: 6 hours Half-life elimination: 12 hours Excreted by the urine Endothelial membrane acts as a barrier to large molecules therefore stays intravascular Voluven Max dose: 50mL/kg/day Children <2yrs: 7-25mL/kg Children 2-12 not studied Children >12 yrs: max dose of 50mL/kg/day Contraindicated in renal failure/hemodialysis Caution in hypernatremia or hyperchloremia Contraindicated in intracranial bleeding Reference: Product monograph Voluven and the kidney Cochrane Review: Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function (Review) 34 randomized trials reviewed In surgical or trauma patients, no difference in renal failure Increased renal failure in sepsis Pentaspan 10% Pentastarch in 0.9% NaCl Osmolality: 326mOsm/Kg pH 5.o Plasma expansion approximately 1:1 infused volume What is it made of? Pentastarch 10.0g Sodium 154 mmol Chloride 154 mmol Pentaspan Duraction of action 18-24 hours Half-life elimination: 1.9 days Renally excreted Max dose: 2000mL/24hrs or 28mL/kg/day Pentaspan Major adverse reactions: coagulopathy Contraindicated in renal disease with oliguria or anuria No established safety in children Use beyond 72 hours has not been studied Reference: Product monograph 5% Albumin Isotonic, iso-oncotic Osmolarity: 308 What is it made of? Sodium 154 mmol Chloride 154 mmol Albumin 5gm/100mL = 5gm/L 5% Albumin Blood Product Derived Plasma expansion 1:1 with volume infused Initial dose: 25g, may be repeated in 15-30 minutes if response inadequate Max dose: 250g in 48hrs Can also be given for hypoproteinemia at 0.5-1g/kg/dose, repeated every 1-2 days as needed 5% Albumin Use in patients unresponsive to crystalloid therapy and when nonprotein colloids are contraindicated 25% Albumin Osmolarity: 308 Isotonic, hyper-oncotic What is it made of? Sodium 154 mmol Chloride 154 mmol Albumin 25gm/100mL = 25gm/L 25% Albumin High oncotic pressure Draws fluid into interstitial space Incremental increase in plasma volume 4-5 times greater than volume infused Interstitial fluid decreases 4 times greater than volume infused 25% Albumin Use is indicated in patients in whom fluid and sodium intake is restricted or when needing to shift interstitial fluid into plasma where hypovolemia associated with edema Same dosing as 5% (25g initial dose, max dose 250g/48hrs) May dilute in normal saline Blood Products FFP: contains plasma with a few cells pRBC: RBC with some plasma Fluid in blood products are isotonic/oncotic/osmotic therefore no shifting of fluid All transfusions stay in intravascular space What are crystalloids? IV Fluids comprising of various amounts of electrolytes and sugar Used for fluid expansion, maintenance infusion, correction of electrolytes Divided into isotonic, hypotonic, hypertonic fluids Advantages of crystalloids Inexpensive Little risk of allergy/transfusion reaction Available crystalloids Isotonic Hypertonic Normal Saline (0.9%) Ringer’s Lactate Hypertonic Saline (3%) Hypotonic 0.45% NaCl D5W Isotonic crystalloids Workhorse of shock resuscitation Distributes equally through all fluid compartments Larger volumes (3:1) for intravascular filling Normal Saline (0.9%) Sodium - 154 mmol Chloride - 154 mmol Osmolarity =154 x 2 = 308 Iso-osmolar, Isotonic, Hypo-oncotic pH=5 Normal Saline Bolus of 1L Na keeps fluid in extracellular space Distributes proportionally in extracellular space Normal Saline Potential adverse effects: Hypernatremia and hyperchloremic metabolic acidosis Preferred in the presence of hyperkalemia, hypercalcemia, hyponatremia, hypochloremia, or metabolic alkalosis Ringer’s Lactate Sodium 130 mmol Potassium 4 mmol Calcium 1.4 mmol Chloride 109 mmol Lactate 28 mmol Osmolarity=130+4+1.4+109+28 = 273 Hypotonic, Hypo-oncotic pH=6.5 Ringer’s Lactate Bolus Similar to NS Distributes proportionally in extracellular compartment Ringer’s Lactate Balanced salt solution despite similar tonicity as NS Designed to mimic extracellular fluid Provides a HCO3- precursor Useful for GI losses and extracellular fluid volume deficits Ringer’s Lactate Lactate may provide a buffer to metabolic acidosis Implicated in promoting respiratory acidosis Possible immune-modulating function Hypertonic saline solutions Combines ease of crystalloid with the tonicity of colloids Promotes influx of fluid from the interstitial space Rapid, low-volume resuscitation for hypovolemic shock Hypertonic Saline 3% NaCl Sodium: 513 Chloride: 513 pH: 5.0 7.5% NaCl Sodium: 1,283 Chloride: 1,283 Hypertonic saline solutions Possible hypernatremia and hyperosmolarity Reports of hypokalemia, metabolic acidosis, and impaired platelet aggregation Risks: Central pontine myelinolysis with rapid infusion Renal compromise with high sodium and osmolar loads Hypotonic solutions Distribute throughout the TBW compartment Not for volume expansion Replace free water deficits D5W Dextrose - 5gm/100ml = 50gm/litre Osmolarity=252 = hypo-osmolar Hypotonic, Hypo-oncotic pH=4.0 Bolus of D5W Distributed proportionally between ICF and ECF Water crosses cellular membrane D5-1/2NS Sodium 77 mmol Chloride 77 mmol Dextrose 50gm/litre Osmolarity=252 + 77 +77 = 406 Hypotonic, Hypo-oncotic Bolus of 1L D5-1/2NS 500 cc NS and 500 cc D5 D5 redistributes everywhere NS extracellular ICF up 300cc, ECF up 600 cc Resuscitation. Does it matter what fluid I give? How do I fluid resuscitate a…? Trauma patient? Septic patient? Burn patient? Pediatric patient? Choice of fluid. Intuitively crystalloids or hypertonic saline, BUT… The bulk of available evidence indicates that neither colloids or crystalloids provide a survival benefit in ICU patients But not in patients with traumatic brain injury Choice of fluid. A comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit Conclusion: “In patients in the ICU, use of either 4 percent albumin or normal saline for fluid resuscitation results in similar outcomes at 28 days” The primary outcome measure was death from ANY cause within 28 days after randomization The SAFE Study Investigators. (2004). A comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit. New England Journal Medicine, 350, 2247-2256. Choice of Fluid. Plain language summary: “No evidence that colloids are more effective than crystalloids in reducing mortality in people who are critically ill or injured” Perel et al. (2007). Cochrane Database of Systematic Reviews, 4 Choice of Fluid. Conclusions: “In this post hoc study of critically ill patients with traumatic brain injury, fluid resuscitation with albumin was associated with higher mortality rates than was resuscitation with saline.” Myburgh J, et al., (2007). Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal Medicine, 357, 874-884 Hypertonic saline: - have greater ability to expand blood volume, and thus elevate blood pressure Plain language summary: “more evidence needed as to the best concentration of crystalloid to use in resuscitation fluids”. Bunn, Roberts, Tasker, & Trivedi (2008). Cochrane Database of Systemic Reviews, 3 Choice of fluid. A reasonable approach: Tailor the type of resuscitation fluid to the specific clinical condition Hypovolemia secondary to dehydration (uniform loss of extracellular fluid)- crystalloid fluid Hypovolemia secondary to hypoalbuminemia (fluid shift)- colloid fluid (25% albumin) Trauma Traditional resuscitation approach: Establish vascular access with 2 large bore IV’s, and: (At the moment) warmed crystalloid solutions are recommended for initial resuscitation Alternative is hypertonic saline, but no evidence Initial warmed fluid bolus given as rapidly as possible; 1 to 2 L for adults, 20 ml/kg for pediatric patients Initial fluid and blood requirement is difficult to predict on initial evaluation of the patient Important to asses the patient’s response! Estimated Blood Loss Based on Patient’s Initial Presentation “Class I” “Class II” “Class III” “Class IV” EBL EBL EBL EBL <750cc <15% of TBV 750cc – 1500cc 15 – 30% of TBV 1.5L – 2L 30 – 40% of TBV >2L >40% of TBV S&S S&S HR: increased Pulse Pressure: decreased BP: no change HR: increased BP: decreased MS: agitated Urine Output: decreased Tx Tx S&S None/minimal Tx Crystalloids Crystalloids 1. Crystalloid (1 – 2L) 2. Transfusion (1 – 2units) 3. Identify source of Bleed(*5) S&S HR: increased BP: decreased (<60) MS: decreased Tx 1. 2. 3. 4. Crystalloid (2L) Transfusion (2 – 4 units) Identify source of Bleed(*5) OR American College of Surgeon’s Committee on Trauma (2008). Advance Trauma Life Support for Doctors, 8th Ed. Chicago, IL: American College of Surgeons Trauma cont. In penetrating trauma with hemorrhage, delaying aggressive fluid resuscitation until definitive control may prevent additional bleeding Bickell et al. (1994). Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. New England Journal of Medicine, 331, 1105-1109 Trauma, cont. Concept of “Permisive Hypotension”: AKA hypotensive resuscitation Balancing goal of organ perfusion with the risks of rebleeding by accepting lower than normal blood pressure strategy to bridge to definitive surgical control Does not apply to patients with head injury Supported by many animal studies • Mapstone, Roberts, & Evans (2003). Fluid resuscitation strategies: A systematic review of animal trials. Journal of Trauma, 55, 571-587 Plain language summary: No evidence from trials to support or not to support the use of early or larger volume intravenous fluid in uncontrolled bleeding Kwan, Bunn, & Roberts (2003). Cochrane Database of Systematic Reviews, 3 Trauma, cont. Severe injury and hemorrhage result in consumption of coagulation factors Measure INR, PTT, platelet count, and fibrinogen levels Major brain injury-tissue thromboplastin Massive fluid resuscitation worsens coagulopathy Maegele et al. (2007). Early coagulopathy in multiple injury: An analysis from the German Trauma Registry on 8724 patients. Injury, 38, 298-304. Trauma, cont. Patients transiently responding, or not responding to resuscitation need blood! Recent trend towards administering blood component therapy in equal proportions • Conclusions: “The transfusion of plasma to RBCs in a 1:1 ratio is a rapid treatment that improves survival for patients at risk of hemorrhagick shock. We suggest that the empiric ratio of plasma to RBC should approximate 1:1 for patients with traumatic injuries requiring massive transfusions.” Borgman MA, et al. (2007). The ratio of blood products transfused affects mortality in patients receiving massive tranfusions at a combat support hospital. Journal of Trauma, 63, 805-813. Evaluation of Fluid Resuscitation evaluate blood pressure, pulse pressure, and pulse rate Improvements in CVP, skin circulation are difficult to quantitate Base deficit/lactate Urinary output sensitive indicator of renal perfusion 0.5 ml/kg/hr in adults, 1 ml/kg/hr in pediatric patients, children under 1 yr 2 ml/kg/hr Sepsis SIRS- tachycardia (HR>90), tachypnea (RR>20 or PacO2,32 mmHg), leukocytosis (WBC>12) or leukopenia “Time is tissue” Use “Early Goal Directed Therapy” as a guideline CVP of 8-12, MAP >65, urine output >0.5 ml/kg/hr, ScvO2=70% Rivers, E. et al. 2005 CMAJ. 173(9) 1054-1065. Sepsis, cont. Rapid, repeated 500 mL boluses of crystalloid or colloid up to an initial resuscitation volume of 20-40 mL/kg body weight If Scv02 remains below 70% after attempted optimization, give PRBC’s to achieve a hematocrit above 30% But.. as always, treat the patient, not the numbers! Frequently re-asses progress! Burns Burns covering more than 15% of the total body surface area in adults and more than 10% in children warrant formal resuscitation Most commonly used resuscitation formula is the Parkland formula Titrate rate against urine output: Starting point for resuscitation is the time of injury, not the time of admission Wallace Rule of Nines Burns, cont. Parkland formula for burn resuscitation: Total fluid requirement in 24 hours= 4 ml X (TBSA)(%)) X (body weight (kg)). 50% given in the first 8 hours, 50% given in the next 16 hours. Children receive maintenance fluid in addition End Point: • Urine output of 0.5-1.0 ml/kg/hour in adults, 1.0-1.5 ml/kg/hour in children Pediatric Fluid Therapy Goals = prevention of dehydration, electrolyte disorders, ketoacidosis and protein degradation Glucose should be added to prevent ketoacidosis Kids have small amounts of glycogen stores Maintenance fluid: 4-2-1 rule Bolus dose: start with 20cc/kg Pediatric Fluid Therapy Bolus: Normal saline OR Ringer’s Lactate D5-1/2NS + 20mEq/l KCl provides 17calories/100mL, 20% of caloric need Prevents ketoacidosis and minimizes protein degredation D5-0.2NS + 20mEq/l KCl good in children <10kg High water need/kg Morbidity Associated with Over Resuscitation Decreased wound healing, difficulty with wound closure, Decreased gut mobility, abdominal compartment syndrome, bacterial translocation Cellular level: acidosis, large fluid shifts Hemodilution; hemoglobin, clotting actors Coagulopathy; decreased clotting factors, increased bleeding time Cytokine activation; inflammatory cascade, ARDS, renal failure Conclusions Multiple ways to fluid resuscitate individuals Key = frequent reassessment of fluid resuscitation and fluid balance Crystalloids and Colloids are drugs and have complications associated with their use Cater your fluid resuscitation to the patient Watch for signs of fluid overload Conclusions If a patient is not bleeding; Resuscitate according to etiology of illness Evidence to date does not support any crystalloid/colloid more than any other -may consider use of hypertonic saline 7.5% Can use Early Goal Directed Therapy as a guideline Conclusions If the patient is bleeding: Judicious use of fluids: Concept of permissive hypotension until definitive repair In a patient with a head injury: Do not give Albumin! - Avoid hypotension If significant blood loss: • Administer blood products Cater your fluid resuscitation to the patient Watch for signs of fluid overload References American College of Surgeon’s Committee on Trauma (2008). Advance Trauma Life Support for Doctors, 8th Ed. Chicago, IL: American College of Surgeons. Bickell et al. (1994). Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. New England Journal of Medicine, 331, 1105‐ 1109. Borgman et al. (2007). The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. Journal of Trauma, 63, 805‐ 813. Bunn, Roberts, Tasker, & Trivedi (2004). Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database of Systemic Reviews, 3,CD002045. Civetta, Taylor, & Kirby's critical care / edited by Andrea Gabrielli, A. Joseph Layon, Mihae Yu. — 4th ed. Dart, AB., Mutter, TC., Ruth, CA., Taback, SP., Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. The Cochrane Collaboration 2010, Issue 1 Fluid and Electrolyte administration. Policies & Procedures Database, The hospital for Sick Kids, 2008. Hettiaratchy & Papini (2004). Initial management of a major burn: II – Assessment and resuscitation. British Medical Journal, 329,101‐103. Kliegman: Nelson Textbook of Pediatrics, 18th ed. 2007 Saunders, Elsevier References Klingensmith, Mary E.; Chen, Li Ern; Glasgow, Sean C.; Goers, Trudie A.; Melby, Spencer J. Washington Manual of Surgery, 5th Edition, 2008 Lippincott Williams & Wilkins Kwan, Bunn, & Roberts (2003). Timing and volume of fluid administration for patients with bleeding. Cochrane Database of Systematic Reviews, 3, CD002245. Maegele et al. (2007). Early coagulopathy in multiple injury: An analysis from the German Trauma Registry on 8724 patients. Injury, 38, 298‐304. Mapstone, Roberts, & Evans (2003). Fluid resuscitation strategies: A systematic review of animal trials. Journal of Trauma, 55, 571‐587. Marino (2007). The ICU Book, 3rd Ed. Philadelphia, PA: Lippincott Williams & Wilkins. Myburgh J, et al. (2007). Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal Medicine, 357, 874‐884. Pentaspan Product Monograph Perel et al. (2007). Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews, 4, CD000567. Rivers et al. (2005). Early and innovative interventions for severe sepsis and septic shock: Taking advantage of a window of opportunity. Canadian Medical Association Journal, 173(9) 1054‐1065. The SAFE Study Investigators (2004). A comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit. New England Journal Medicine, 350, 2247‐2256. Townsend, CM., Beauchamp, RD., Evers, BM., Mattox, KL., Sabiston’s Textbook of Surgery, 18th ed., Saunders, 2007 Vincent, J., Weil, H., Fluid challenge revisted. Crit Care Med 2006 Vol. 34, No. 5 Voluven Product Monograph